rpoB Mutations in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy

Journal of Clinical Microbiology

Volumn 37, Issue 4, 1999, Pages 1197-1199

  Pozzi, G ^a   Meloni, M ^b   Iona, E ^c   Orru G ^a   Thoresen, O F ^c   Ricci, M L ^c   Oggioni, M R ^a   Fattorini, L ^c   Orefici, G ^c  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; CODON; GENE MUTATION; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUBERCULOSIS;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0033026532     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.4.1197-1199.1999     Document Type: Article

References (19)

1. Bass, J. B., Jr., L. S. Farer, P. C. Hopewell, R. O'Brien, R. F. Jacobs, F. Ruben, D. E. Snider, Jr., and G. Thornton, Jr. 1994. Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. Am. J. Respir. Crit. Care Med. 149:1359-1374.
2. Caugant, D. A., P. Sandven, J. Eng, J. T. Jeque, and T. Tonium. 1995. Detection of rifampin resistance among isolates of Mycobacterium tuberculosis from Mozambique. Microb. Drug Resist. 1:321-326.
3. Cooksey, R. C., G. P. Morlock, S. Glickman, and J. T. Crawford. 1997. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J. Clin. Microbiol. 35:1281-1283.
4. Heifets, L. B. 1991. Antituberculosis drugs: antimicrobial activity in vitro, p. 14-49. In L. B. Heifets (ed.), Drug susceptibility in the chemotherapy of mycobacterial infections. CRC Press Inc., Boca Raton, Fla.
5. Heym, B., N. Honore, C. Pernot-Truffot, A. Banerjee, C. Schurra, W. R. Jacobs, Jr., J. D. A. van Embden, J. H. Grosset, and S. T. Cole. 1998. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 344:293-298.
6. Kapur, V., L.-L. Li, S. Iordanescu, M. R. Hamrick, A. Wanger, B. N. Kreiswirth, and J. M. Musser. 1994. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase b subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J. Clin. Microbiol. 32:1095-1098.
7. Matsiota-Bernard, P., G. Vrioni, and E. Marinis. 1998. Characterization of rpoB mutations in rifampin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J. Clin. Microbiol. 36:20-23.
8. Moghazeh, S. L., X. Pan, T. Arain, C. K. Stover, J. M. Musser, and B. N. Kreiswirth. 1996. Comparative antimycobacterial activities of rifampin, rifampentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations. Antimicrob. Agents Chemother. 40:2655-2657.
9. Morris, S., G. H. Bai, P. Suffys, L. Gomez-Portillo, M. Fairchok, and D. Rouse. 1995. Molecular mechanisms of multiple drug resistance in clinical isolates of Mycobacterium tuberculosis. J. Infect. Dis. 171:954-960.
10. Musser, J. M. 1995. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:496-514.
11. Nachamkin, I., C. Kang, and M. P. Weinstein. 1997. Detection of resistance to isoniazid, rifampin. and streptomycin in clinical isolates of Mycobacterium tuberculosis by molecular methods. Clin. Infect. Dis. 24:894-900.
12. Ohno, H., H. Koga, S. Kohno, T. Tashiro, and K. Hara. 1996. Relationship between rifampin MICs for rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob. Agents Chemother. 40:1053-1056.
13. Ohno, H., H. Koga, T. Kuroita, K. Tomono, K. Ogawa, K. Yanagihara, Y. Yamamoto, J. Miyamoto, T. Tashiro, and S. Kohno. 1997. Rapid prediction of rifampin susceptibility of Mycobacterium tuberculosis. Am. J. Respir. Crit. Care Med. 155:2057-2063.
14. Ovchinnikov, Y. A., G. S. Monastyrskaya, V. V. Gubanov, S. O. Guryev, O. Y. Chertov, N. N. Modyanov, V. A. Grinkevich, I. A. Makarova, T. V. Marchenko, I. N. Polovnikova, et al. 1981. The primary structure of Escherichia coli RNA polymerase. Nucleotide sequence of the rpoB gene and amino-acid sequence of the beta-subunit. Eur. J. Biochem. 116:621-629.
15. Rinder, H., P. Dobner, K. Feldmann, M. Rifai, G. Bretzel, S. Rusch-Gerdes, and T. Loscher. 1997. Disequilibria in the distribution of rpoB alleles in rifampicin-resistant M. tuberculosis isolates from Germany and Sierra Leone. Microb. Drug Resist. 3:195-197.
16. Taniguchi, H., H. Aramaki, Y. Nikaido, Y. Mizuguchi, M. Nakamura, T. Koga, and S.-I. Yoshida. 1996. Rifampicin resistance and mutation of rpoB in Mycobacterium tuberculosis. FEMS Microbiol. Lett. 144:103-108.
17. Telenti, A., P. Imboden, F. Marchesi, D. Lowrie, S. Cole, M. J. Colston, L. Matter, K. Schopfer, and T. Bodmer. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647-650.
18. van Soolingen, D., P. E. W. de Haas, P. W. M. Hermans, and J. D. A. van Embden. 1994. DNA fingerprinting of Mycobacterium tuberculosis. Methods Enzymol. 235:196-205.
19. Williams, D. L., C. Waguespack, K. Eisenach, J. T. Crawford, F. Portaels, M. Salfinger, C. M. Nolan, C. Abe, V. Sticht-Groh, and T. P. Gillis. 1994. Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob. Agents Chemother. 38:2380-2386.